Page last updated: 2024-10-27

flurbiprofen and Pain, Breakthrough

flurbiprofen has been researched along with Pain, Breakthrough in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
"To compare the treatment effect reducing cancer-related multiple breakthrough pain (BTP) between immediate release morphine sulfate (IRMS) and flurbiprofen axetil."7.79Intravenous flurbiprofen axetil to relieve cancer-related multiple breakthrough pain: a clinical study. ( Cheng, X; Hao, J; Shao, Y; Wang, K; Yan, Z, 2013)
"To compare the treatment effect reducing cancer-related multiple breakthrough pain (BTP) between immediate release morphine sulfate (IRMS) and flurbiprofen axetil."3.79Intravenous flurbiprofen axetil to relieve cancer-related multiple breakthrough pain: a clinical study. ( Cheng, X; Hao, J; Shao, Y; Wang, K; Yan, Z, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hao, J1
Wang, K1
Shao, Y1
Cheng, X1
Yan, Z1

Other Studies

1 other study available for flurbiprofen and Pain, Breakthrough

ArticleYear
Intravenous flurbiprofen axetil to relieve cancer-related multiple breakthrough pain: a clinical study.
    Journal of palliative medicine, 2013, Volume: 16, Issue:2

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Breakthrough Pain; Case-Control Studies

2013
chemdatabank.com